These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 21525578

  • 1. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
    Afzal N, Abbas S, Ahmed A, Arif M, Javeed K.
    Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
    [Abstract] [Full Text] [Related]

  • 2. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
    Zumrutdal A, Ozer B, Singan M, Micozkadioglu H, Sezer S, Ozdemir FN, Haberal M.
    Ren Fail; 2007 Jul; 29(1):85-90. PubMed ID: 17365915
    [Abstract] [Full Text] [Related]

  • 3. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V, Rosati A, Paoletti S, Ferrandello P, Migliori M, Beati S, Bernabini G, Daini R, Casani A, Angelini D, Parrini M, Rossi A, Petrone I, Barsotti G, Donadio C, Donati G, Grazi G, Manca Rizza G, Garosi G, Sansoni E, Braccagni B, Sidoti A, Boracelli D, Biagioli M, Moriconi L, Finato V, Mannarino A, Grimaldi C, Pansa F, Imperiali P, Mura C, Bianchi S, Bigazzi R.
    Blood Purif; 2011 Jun; 32(1):7-14. PubMed ID: 21242686
    [Abstract] [Full Text] [Related]

  • 8. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
    Batchoun RG, Al-Najdawi MA, Al-Taamary S.
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M.
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rahim Rezaee SA.
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [Abstract] [Full Text] [Related]

  • 12. The influence of hepatitis C infection activity on oxidative stress markers and erythropoietin requirement in hemodialysis patients.
    Tutal E, Sezer S, Ibis A, Bilgic A, Ozdemir N, Aldemir D, Haberal M.
    Transplant Proc; 2010 Jun; 42(5):1629-36. PubMed ID: 20620489
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
    Resić H, Sahović V, Mesić E, Leto E.
    Acta Med Croatica; 2003 Jun; 57(1):39-42. PubMed ID: 12876861
    [Abstract] [Full Text] [Related]

  • 15. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
    Kaysen GA, Levin NW, Mitch WE, Chapman AL, Kubala L, Eiserich JP.
    Blood Purif; 2006 Jun; 24(5-6):508-16. PubMed ID: 17077623
    [Abstract] [Full Text] [Related]

  • 16. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study.
    Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM.
    J Med Virol; 2006 May; 78(5):569-73. PubMed ID: 16555284
    [Abstract] [Full Text] [Related]

  • 17. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [Abstract] [Full Text] [Related]

  • 18. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N, Einollahi N, Nabatchian F, Moradi Sarabi M, Zarebavani M.
    Acta Med Iran; 2012 Feb; 50(3):197-202. PubMed ID: 22418989
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.